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Asthma is one of the most widespread chronic respiratory conditions. This disease
primarily develops in childhood and is influenced by different factors, mainly genetics
and environmental factors. DNA methylation is an epigenetic mechanism which may
represent a bridge between these two factors, providing a tool to comprehend the
interaction between genetics and environment. Most epidemiological studies in this field
have been conducted using blood samples, although DNA methylation marks in blood
may not be reliable for drawing exhaustive conclusions about DNA methylation in the
airways. Because of the role of nasal epithelium in asthma and the tissue specificity
of DNA methylation, studying the relationship between DNA methylation and childhood
asthma might reveal crucial information about this widespread respiratory disease. The
purpose of this review is to describe current findings in this field of research. We will
present a viewpoint of selected studies, consider strengths and limitations, and propose
future research in this area.
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BACKGROUND
Asthma is a chronic inflammatory condition that affects the airways and is defined by recurrent
episodes of wheeze, breathlessness, chest tightness and/or cough associated with variable expiratory
airflow limitation (1). Despite environmental exposures explaining about one third of risk factors
for asthma, genetic factors are also responsible for vulnerability to the disease (1–3). Epigenetic
marks have been suggested as a link between genetic predisposition and environmental exposure,
providing a special chance to clarify the relationship between genetics and environment (4, 5).
Much evidence suggest that epigenetic processes, such as DNA methylation, play a role in
asthma susceptibility (6). Although most of epidemiological studies have been conducted using
blood samples, there is evidence that the study of the nasal methylome allows for making more
reliable conclusions about DNAmethylation in the lungs. Recently, Brugha et al. provided evidence
that the bronchial epithelium and blood are twice as distant as the bronchial and nasal epithelium,
emphasizing that DNA methylation in blood samples may not be informative enough to draw
conclusions about methylation marks in the airways (7). Thanks to the tissue specificity, the DNA
methylation of nasal epithelium may be crucial for understanding the complex molecular patterns
involved in asthma. Currently, few studies considered nasal epithelium in pediatric asthma showing
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that the nose is both a remarkable and less-invasive surrogate
for the bronchi in transcriptional profiling studies (8) and
discriminates between stable and acute asthma in children (9).
One of the first studies in this field was performed by
Baccarelli et al. in 2012 (10). Using pyrosequencing, the authors
analyzed the DNA methylation of interleukin-6 (IL-6) and nitric
oxide synthase (iNOS) promoters, and DNA methylation of
repetitive elements: Alu (Arthrobacter luteus) and LINE-1 (Long
Interspersed Nuclear Elements). This revealed that asthmatic
children who had higher values of fractional exhaled nitric
oxide (FeNO) showed a hypomethylation of the IL-16 and iNOS
promoters. More recently, few studies performed epigenome-
wide association analysis between the nasal methylome and
pediatric asthma (11–14).
In this review, we aim to summarize current evidence
about the relationship between DNA methylation in nasal
epithelium and childhood asthma. Through this, we will present
a viewpoint of selected studies considering the current strengths
and limitations and introducing a future scenario in this
research field.
EPIGENETICS MECHANISM: THE BASICS
The term epigenetics refers to DNA modifications that do not
change the gene sequence. Modifications in DNA methylation,
histone proteins that are responsible for DNA packaging,
and microRNAs patterns can change genome function under
different environmental stimuli (15). DNA methylation is
a well-known epigenetic marker. This modification occurs
in the cytosine residue of cytosine-phosphate-guanine (CpG)
dinucleotides. Approximately 80% of all CpGs in the mammalian
genome are estimated to be methylated. The remaining CpG
residues, referred to as CpG islands, are predominantly situated
in promoters of genes that are constitutively or inducible
active. Usually these promoters are >500 base pairs long
and more than 55% of each promoter consist of GC (16,
17). The methylation of these sites is produced by specific
enzymes, the DNAmethyltransferases (DNMTs). These enzymes
are involved in several mechanisms such as transcriptional
regulation, genomic stability, chromatin structure modulation, X
chromosome inactivation, and the silencing of DNA transposable
elements (6).
NASAL EPITHELIUM SAMPLING
The nasal brushing technique is the most commonly used
in children for collecting nasal epithelium samples (10–14).
This method has been widely used to study chronic airway
diseases including cystic fibrosis, asthma, and other obstructive
respiratory diseases. Cells in nasal epithelium have properties
resembling bronchial epithelial cells and nasal brushing is much
less invasive than bronchial brushing or bronchoalveolar lavage;
thus, this technique represents a good surrogate model for lower
respiratory tract studies (18). Usually, cells in the nasal epithelium
are collected by brushing the inferior turbinate with a cytobrush,
but it is also possible to collect nasal cells from the anterior
nares by brushing the nasal bone and vigorously scrubbing the
nares (19).
EVIDENCE OF THE ROLE OF DNA
METHYLATION IN NASAL EPITHELIUM ON
CHILDREN WITH ASTHMA
To locate evidence for the review topic, we conducted a
keyword search through the PubMed database including the
following criteria: (1) biological sample: nasal epithelium; (2)
study population age: between 1 month and 20 years; (3)
study area: metropolitan; (4) outcomes of interest: atopic and
non-atopic asthma; (6) biological modification investigated:
DNA methylation; (7) type of analysis: epigenome-wide or
pyrosequencing analysis; (8) studies published from 2012 to 2019,
as this range includes the first study published on this topic
and the most recent studies; (9) language: English. We used the
following search strategy: children [ALL] ANDDNAmethylation
[ALL] AND nasal epithelium [ALL]; nasal epithelium. Abstracts
(i.e., conference proceedings) and reviews were excluded. Among
the 15 studies identified, eleven were excluded due to the
following reasons: two studies used nasal cells to replicate results
from other tissues, so that nasal epithelium was not the main
tissue investigated (19, 20); one study analyzed DNAmethylation
in relation to single-nucleotide polymorphisms (SNPs) and gene
expression in childhood asthma (21); seven studies did not
focus the association between DNA methylation and asthma,
but other topics such as lung function and corticosteroid
treatment response (7, 22–27); one study was conducted on
newborns and findings were verified in another cohort of
children to characterize early DNA methylation patterns in
airways depending on gender (28). Finally, 4 studies were
included in this review (Table 1).
In 2017, Yang et al. (11) compared DNA methylation markers
in genome and gene expression in 36 children with persistent
atopic asthma and 36 non-asthmatic children. The results from
this analysis were verified using a child’ population of 30 subjects
(aged 10 to 12 years) with atopic asthma vs. the same control
group, as shared control samples [N = 36], and validated in
an independent adult population (ranged 27 to 74 years) with
atopic asthma [N = 12] and without asthma [N = 12]. The
authors identified 119 epigenome-wide significant differentially
methylated regions (DMRs) associated with 118 unique genes
and 118 differentially methylated probes (DMPs) associated
with 107 unique genes. Among 186 allergic asthma-associated
differentially methylated genes (DMR and/or DMP), they found
genes with an established role in asthma and atopy, immunity,
in addition to genes related to extracellular matrix, cell adhesion,
epigenetic regulation, and airflow obstruction. Gene expression
analysis identified 53 differentially expressed genes. Among those
genes, 32 had significant methylation-expression relationships
within 5 kb. This was the first epigenome-wide association study
on childhood asthma. Advantages of this type of analysis are
that it detects DNA methylation signals in different gene regions
and eventually allows to study how the methylation status of
these gene regions relates to their expression. This study detected
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TABLE 1 | Main characteristics of the four studies selected.
References Title of manuscript Cohort Age Methods Main Findings
Yang et al. (11) The nasal methylome and
childhood atopic asthma
36 children with persistent
atopic asthma
36 control subjects
1st validation
30 asthmatic children
36 control subjects
2nd validation
12 adults with atopic
asthma
12 control subjects
10-12 years Illumina Infinium Human
Methylation450 BeadChips
119 DMRsa associated with 118
unique genes and 118 DMPsb
associated with 107 unique
genes.
Zhang et al. (12) Nasal DNA methylation is
associated with childhood
asthma
29 sibling pairs discordant
for asthma
54 sibling pairs
for verification
Asthmatics 12.01
years
No-Asthmatics
11.35 years
Illumina Infinium Human
Methylation450 BeadChips
Three CpGsc associated with
asthma (cg00112952,
cg14830002, cg23602092).
Forno et al. (13) DNA methylation in nasal
epithelium, atopy, and atopic
asthma in children:
genome-wide study
483 Puerto Rican children
72 African American
children
432 European children
9-20 years Illumina Infinium Human
Methylation450 BeadChips
30 top CpGsc in or near genes
implicated in epithelial barrier
function and in other genes
involved in airway epithelial
integrity and immunity
Cardenas et al.
(14)
The nasal methylome as
biomarker of asthma and airway
inflammation in children
547 children 12.9 years Infinium MethylationEPIC
BeadChip
20 top differentially methylated
CpGsc associated with current
asthma
aDifferentially methylated region (DMR).
bDifferentially methylated probe (DMP).
cCitosine-phosphate-guanine (CpGs).
new genes with an expression status that can be involved in
childhood asthma.
In 2018, Zhang et al. (12) used a cohort of 29 sibling pairs
discordant for asthma. This epigenome-wide analysis identified
six CpG sites for which methylation was nominally associated
with asthma status. Four of themwere placed in promoter regions
and three of these sites were verified in a cohort of 54 sibling
pairs through pyrosequencing. Two CpG sites (cg00112952 and
cg14830002) were identified within the promoter region of
OR2B11(olfactory receptor family 2 subfamily B member 11),
and the other was located in the TET1 (tet methylcytosine
dioxygenase 1) promoter (cg23602092), which was already
identified in a previous study on children (26). The OR2B11 is
a gene located in chromosome 1 which encodes an olfactory
receptor that interacts with odorant molecules in the nose to
initiate a neuronal response. The protein encoded by TET1 is a
demethylase that belongs to the TET (ten-eleven translocation)
family. Interestingly, a previous study in humans (26) proposed a
role forTET1 in the pathogenesis of pediatric asthma. The finding
that cg14830002 is associated with allergies in non-asthmatics
and that cg23602092 is associated with asthma symptoms reveals
new disease-contributing epigenetic mechanisms and novel
CpG sites in nasal epithelial cells which could serve as useful
asthma biomarkers.
In 2019, Forno et al. (13) carried out a genome-wide study
of DNA methylation in nasal epithelium and atopy or atopic
asthma in 483 Puerto Rican children and young adults (9-
20 years). The authors identified specific methylation profiles
associated with atopy or atopic asthma. In particular, 30 top
CpG sites were selected. Many genes reported in this study
are involved in epithelial barrier mechanisms and immunity,
like CDH26 (cadherin 26), CDHR3 (cadherin related family
member 3), GJA4 (gap junction protein alpha 4), and CAPN14
(calpain 14). Among genes of the 30 top CpG sites, there
were also genes involved in atopy and inflammation like
NTRK1 (neurotrophic receptor tyrosine kinase 1), and lung
function like SLC9A3 (solute carrier family 9 member A3). The
authors detected a hypomethylation and increased expression
of NTRK1 in atopy; this gene is induced by interleukin 13
(IL-13) and is increased in eosinophilic esophagitis. SLC9A3
gene codes for an Na+/H+ exchanger and has been linked
to reduced lung function in cystic fibrosis. Furthermore, the
authors described two genes, which are expressed in many
tissues, including the lung: PCSK6 (proprotein convertase
subtilisin/kexin type 6) encodes a protease constitutively
secreted in the extracellular matrix, while the product of
METTL1 (methyltransferase like 1) gene contains a conserved
S-adenosylmethionine-binding motif and is inactivated by
phosphorylation. Notably, the 30-CpG panel was able to
discriminate atopic subjects in three cohorts regardless of racial
and ethnic differences.
In the same year Cardenas et al. (14) performed an
epigenome-wide association study (EWAS) in children with
asthma (mean age 12.9 years) and healthy controls. Using
nasal swabs, the authors reported the top 20 differentially
methylated CpGs associated with current asthma compared
to non-asthmatic subjects. They also reported the differential
DNA methylation of genomic regions of three genes previously
associated with asthma: TNIP-1 (TNFAIP3 interacting protein
1), IL-13, and CHI3L1 (chitinase 3 like 1) (29–31), showing that
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the nasal methylome may serve as a reliable biomarker of asthma
in children.
According to the findings described in the aforementioned
four studies, a few loci do overlap. In the 30 top CpGs found
by Forno et al. (13), GJA4 and METTL1 sites overlap with CpGs
previously described in the study by Yang et al. (11), which had
shown a hypomethylation in these sites in asthma cases when
compared to controls. Interestingly, Forno et al. (13) replicated
their top results in the Yang and colleague’s cohort and 28 of
30 CpGs were significant (p-value < 0.01). Among the results
described (11, 13), in both studies PCSK6 was hypomethylated
in children with atopy or atopic asthma compared to controls.
Cardenas et al. (14) found two CpGs, cg22855021 in TSHR
(thyroid stimulating hormone receptor) and cg24707200 in
NTRK1, associated with allergic asthma and also overlapping the
top results described in the study by Forno et al. (13). The authors
replicated their top results in Forno et al. (13) and Yang et al.
(11) cohorts, finding some genes which appeared significant in
both the cohorts. In particular, they observed significant sites
in EPX (eosinophil peroxidase) and EVL (Enah/Vasp-like) genes
for asthma.
The top five results of each study selected in the current
review are described in Table 2. Overall, all these studies
identified two main groups of loci: those in genes related to
immunity, like ALOX15 (arachidonate 15-lipoxygenase), and
those in genes involved in epithelial cells function and integrity
like receptor, extracellular matrix protein and connexin as GJA4,
OR2B11, NTRK1. These findings proved the suitability of using
the nasal methylome in research settings and pave the way
toward developing a nasal methylation panel for future clinical
applications in childhood asthma.
COMPARISON OF SELECTED STUDIES
All the studies selected in the current review were focused on
asthma and atopic asthma (11–14). In all the studies asthma was
defined by a medical diagnosis. In particular, Yang et al. (11)
defined asthma following these criteria: a physician diagnosis and
positive skin prick-test to at least one indoor aeroallergen. Zhang
et al. (12) used a diagnosis of asthma acquired from parental
reports and confirmed by medical records. Forno et al. (13)
described atopic asthma as a doctor diagnosis plus at least one
episode of wheeze in the last 12 months and at least one positive
IgE to common aeroallergens. Finally, in the study by Cardenas
et al. (14), asthma was obtained from parental report of a medical
diagnosis plus report of wheeze or asthma medication in the
past year and any positive IgE to common indoor or outdoor
aeroallergens. Only Zhang et al. (12) reported the level of asthma
severity, defined by symptom frequency using a respiratory
symptom score.
With regard to study population, three studies (11, 12, 14)
were performed in cohorts aged around 12 years, while Forno
et al. (13) used a cohort of subjects aged between 9 and 20 years.
The participants’ ethnicities also differ between the studies. In
TABLE 2 | Top five results of the four studies selected.
Gene Official Full Name CpGa or DMRb p-value Chromosome References
ALOX15 Arachidonate 15-lipoxygenase 4541333-4541334 7.82 x 10−4 chr 17 Yang et al. (11)
HLA-DPA1 Major histocompatibility complex, class II, DP alpha 1 33041220-33041697 1.04 x 10 −6 chr 6 Yang et al. (11)
GJA4 Gap junction protein alpha 4 35258778-35258933 6.00 x 10 −3 chr 1 Yang et al. (11)
POSTN Periostin 38172802-38172803 7.25 x 10 −4 chr 13 Yang et al. (11)
LDLRAD3 Low density lipoprotein receptor class A domain containing 3 36030085-36030086 6.23 x 10 −6 chr 11 Yang et al. (11)
OR2B11 Olfactory receptor family 2 subfamily B member 11 cg00112952 0.004 chr 1 Zhang et al. (12)
OR2B11 Olfactory receptor family 2 subfamily B member 11 cg14830002 0.001 chr 1 Zhang et al. (12)
TET1 Tet methylcytosine dioxygenase 1 cg23602092 0.016 chr 10 Zhang et al. (12)
ATP9B Atpase phospholipid transporting 9B cg26017880 0.018 chr 18 Zhang et al. (12)
LAMA5 Laminin subunit alpha 5 cg14007090 0.023 chr 20 Zhang et al. (12)
METTL1 Methyltransferase like 1 cg20372759 2.18 × 10−22 chr 12 Forno et al. (13)
GJA4 Gap junction protein alpha 4 cg15006973 8.53 × 10−21 chr 1 Forno et al. (13)
NTRK1 Neurotrophic receptor tyrosine kinase 1 cg24707200 8.53 × 10−21 chr 1 Forno et al. (13)
PDE6A Phosphodiesterase 6A cg08844313 8.53 × 10−21 chr 5 Forno et al. (13)
FBXL7 F-box and leucine rich repeat protein 7 cg00664723 8.53 × 10−21 chr 5 Forno et al. (13)
NOS1AP Nitric oxide synthase 1 adaptor protein cg04165922 0.013 chr 1 Cardenas et al. (14)
COPS8 COP9 signalosome subunit 8 cg10117579 0.013 chr 2 Cardenas et al. (14)
GLB1 Galactosidase beta 1 cg24113459 0.013 chr 3 Cardenas et al. (14)
KCNH2 Potassium voltage-gated channel subfamily H member 2 cg22060869 0.013 chr 7 Cardenas et al. (14)
MSI2 Musashi RNA binding protein 2 cg04727951 0.013 chr 17 Cardenas et al. (14)
The genes highlighted with a light gray background are involved in immunity, the genes highlighted with a dark gray background encode for extracellular matrix, receptor and other
membrane proteins. The genes with a white background are involved in other functions.
aCitosine-phosphate-guanine (CpGs).
bDifferentially methylated region (DMR).
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Yang et al. (11), most of the participants were African Americans
and the rest were Hispanic or Latino; the Zhang et al. (12) cohort
included 96% African Americans; Forno et al. (13) recruited
Puerto Rican children (all Hispanic or Latino); in the study by
Cardenas et al. (14), 67.1% were white and only 16.1% were
black. Since DNA methylation patterns can be influenced by age
and ethnicity, using cohorts with a small age range and with a
homogenous race may limit the generalizability of findings. To
overcome this issue, the results by Yang et al. (11) were validated
in two different cohorts, one of which was a group of adult
Caucasians. To confirm the association between asthma and the
six CpGs found, Zhang and colleagues (12) replicated their results
using data from the Genomic of Secondhand smoke Exposure
in Pediatric (GSEP) study and the Public Inner-City Asthma
Consortium (ICAC) study. The top 30 results by Forno et al. (13)
were replicated in two cohorts: the Yang et al. (11) cohort and the
Prevention and Incidence of Asthma and Mite Allergy (PIAMA)
cohort (32). Finally, also Cardenas et al. replicated their results
using data from Yang et al. (11) and Forno et al. (13).
With regard to nasal sampling, three of the selected studies
used cells from the inferior turbinate (11–13), while Cardenas
et al. (14) performed their analysis on nasal cells from the anterior
nares. The latter technique is easier to perform, and it does not
necessitate a speculum to visualize nasal anatomy or specialized
training. One possible limitation could be the lower average
of respiratory epithelial cells collected (65%) compared to the
inferior turbinate (99%). Nonetheless, the patients’ discomfort is
lower for anterior nares compared to inferior turbinate sampling
(33). This is particularly important in pediatric settings where
collecting samples by brushing the anterior nares would be an
easier and less invasive method for nasal sampling.
The epigenome-wide DNA methylation was measured on
Illumina’s Infinium Human Methylation 450k BeadChip in
three studies (11–13), while Cardenas et al. (14) performed
the measurements with the Infinium MethylationEPIC
BeadChip. The difference between these two arrays is that
the Infinium Human Methylation 450 k BeadChip measures
methylation at 450,000 CpG sites in the genome, while Infinium
MethylationEPIC BeadChip measures methylation at more than
850,000 CpG sites. However, they both use the same technology.
The statistical analysis process was similar among the selected
studies. The authors identified DMRs and they adjusted for
false discovery rates (FDR). However, Yang et al. (11) also
analyzed the gene expression and investigated the relationship
between DMRs and gene expression changes. Zhang et al. (12)
validated the association analysis between DNA methylation
and asthma in candidate sites using pyrosequencing. Forno
et al. (13) determined if significant methylation signals were
associated with gene expression with a transcriptome-wide
analysis. Cardenas et al. (14) also calculated the DNAmethylation
age using an online calculator (https://dnamage.genetics.ucla.
edu/). A further strength in the studies performed by Forno
et al. (13) and Cardenas et al. (14) is the large sample size,
which increased the statistical power. However, to consider the
effect size, Zhang and his colleagues (12) performed a sensitivity
analysis. Finally, whereas three of the selected studies evaluated
the impact of environmental exposures using questionnaires
(11, 13, 14), the study by Zhang et al. (12) used a cohort of
sibling-pairs, which allowed a better control of environmental
confounding factors that may modify DNA methylation and
contribute to asthma. Notably, in all the studies, analyses were
adjusted for smoke exposure, which is known to affect DNA
methylation (33).
FUTURE PERSPECTIVES
Previous studies investigating DNA methylation in blood
samples have detected loci which have been found in the nasal
epithelium. In the study by Forno et al. (13), PCSK6 andMETTL1
were top results, and they had been previously reported in blood
samples in a case-control study performed in asthmatic children
and healthy subjects (34). Also Cardenas et al. (14) reported
genes that were previously discovered in the same study (34),
among which a specific DNA methylation mark, the RUNX3
(RUNX family transcription factor 3), which is involved in T
cell maturation. Findings from epigenome-wide meta-analysis
(20) also suggested that CpG sites involved in inflammation
are associated with asthma in both blood and nasal epithelium.
Accordingly, methylome marks in asthma appear to be stable
in both blood and nasal cells. The relationship between these
two biosamples is still not clear. However, the finding of new
genes in the studies included in the current review suggests
that DNA methylation in the nasal epithelium may provide
more information about airway epithelium pathways involved
in childhood asthma. For instance, a study in nasal epithelium
found for the first time a different methylation status in one
gene, SLC9A3 (solute carrier family 9 member A3), encoding for
an Na+/H+ exchanger which was associated with decreased in
lung function in cystic fibrosis (13). According to the available
evidence, it seems that the methylome changes in blood samples
often involved inflammatory mediators, while the methylome
changes in nasal cells also includedmany proteins of extracellular
matrix and membrane proteins. In particular, the pathway in
nasal cells of asthmatic subjects of genes involved in extracellular
matrix organization and disassembly, collagen catabolic and
metabolic processes, suggests an important role of dysfunctional
airway epithelium in asthma. However, it is necessary to add
more epigenome-wide association analysis and to compare the
results from studies in both the biosamples, in order to clarify
how the information from blood and nasal epithelium differ, and
then optimize their use as biomarkers.
With respect to study design, further studies in longitudinal
cohorts are required to develop predictive nasal methylation
panels suitable for early prediction of asthma, as well as gene
candidate studies to analyze genes found to be significantly
related with asthma. Since sensitization to aeroallergens has been
found to drive an overlap between nasal methylome correlated
with asthma and rhinitis (35), future studies should carefully
consider the coexistence of rhinitis when investigating the
association of DNAmethylation with asthma in nasal epithelium.
Furthermore, it would be fascinating to study the influence of
aging on DNA methylation on this tissue, which is particularly
exposed to environmental factors. Indeed, exploring how the
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estimated epigenetic age differs across a population of the same
age may contribute to understand the effect of endogenous or
exogenous stress factors on aging (36). Epigenetics biomarkers
of aging, otherwise known as “the epigenetic clock,” have already
been studied widely in aging-associated diseases, but evidence
about the epigenetics clock’s role in pediatric allergy and asthma
is scant (36). To our knowledge, only one study used the nasal
methylome to estimate epigenetic age acceleration in children
(14), reporting a significant epigenetic age acceleration in subjects
with current asthma and a greater age acceleration for those
with allergic asthma. Since several age-related changes occur in
lung physiology and morphology and likely have an impact on
asthma, introducing aging information will allow the use of DNA
methylation as a reliable biomarker for asthma in children, and
might contribute to the development of antiaging therapies.
CONCLUSIONS
Studies in children suggest that differences in DNA methylation
are associated with asthma. Emerging findings in this field of
research suggest that the nasal epithelium can be used to reliably
infer the presence of asthma. In particular, recent epigenome-
wide association studies detected new differentially methylated
genes involved in solute carriers and membrane transport
proteins and confirmed the association with genes involved in
the immune system for asthma. However, there is limited overlap
between the studies which prohibits firm conclusions from being
draw on the data. This could be due to different study design and
heterogeneous techniques as well as to the very limited number
of studies in this field. Therefore, extending this analysis using
longitudinal cohorts and analyzing gene candidates selected
from relevant genes could be a promising evolution of this
research area.
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